The cure rate for [diffuse midline glioma] is less than 1%, and the median overall survival is nine to 11 months,” said Dr.

That’s thanks to a major philanthropic commitment from Sarasota’s Brian and Sheila Jellison Family Foundation. As the first ...

They're all talking about HPV, or human papillomavirus. It's the most common sexually transmitted infection, but it's also ...

A neoantigen-targeting personalized cancer vaccine may be effective as adjuvant therapy in patients with high-risk clear cell renal cell carcinoma, phase 1 data suggest.

To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

While January is Cervical Cancer Awareness Month, health experts say getting screened when necessary is important year-round.

Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to macrophage-based therapies, and clues behind why ...

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

In a trial on colon cancer cells, researchers found that at the moment of critical transition — when cancer and normal cells coexist — they were able to flip the molecular switch that allowed normal ...

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...